Vaccine can effectively inhibit virus replication, causes 99% reduction of virus quantity in hamsters

By Sophia Yang, Taiwan News, Staff Writer
2020/08/10 17:18

TAIPEI (Taiwan News) — One of Taiwan's COVID-19 DNA-based vaccine candidates has been shown to cause a significant decline in the amount of virus in the lungs of animals being tested.

Taiwan's National Health Research Institutes (NHRI) announced on Monday (Aug. 10) that it has made progress on a gene-based vaccine co-developed with the Taichung-based biotech company Enimmune. Animal tests have shown that the amount of coronavirus in the lungs of infected hamsters inoculated with the candidate vaccine, developed through genetic engineering, is far smaller than in those uninoculated.

The uninoculated hamsters experienced a loss of weight and vitality. The inoculated hamsters did not.